Hepatitis C "true" late relapse beyond 48weeks of sustained virologic response after direct acting antiviral therapy

J Hepatol. 2017 Apr;66(4):862-863. doi: 10.1016/j.jhep.2017.01.002. Epub 2017 Jan 9.

Authors

Thomas Klag¹, Julia Dietz², Christoph R Werner¹, Julia M Schwarz¹, Ulrich M Lauer¹, Robert Beck³, Nisar P Malek¹, Christoph Sarrazin², Christoph P Berg⁴

Affiliations

¹ Department of Internal Medicine I, University of Tübingen, Tübingen, Germany.
² Department of Internal Medicine I, University of Frankfurt, Frankfurt, Germany.
³ Department of Virology, University of Tübingen, Tübingen, Germany.
⁴ Department of Internal Medicine I, University of Tübingen, Tübingen, Germany. Electronic address: christoph.berg@med.uni-tuebingen.de.

PMID: 28082147
DOI: 10.1016/j.jhep.2017.01.002

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
Drug Therapy, Combination
Hepacivirus*
Hepatitis C
Hepatitis C, Chronic
Humans
Recurrence
Ribavirin
Sustained Virologic Response*
Treatment Outcome

Substances

Antiviral Agents
Ribavirin